Global Project Director

Do you find it interesting to be part of an organization that is dedicated to making a positive impact on people's lives? Are you motivated by the opportunity to transform how we work with (gen)AI in RWE and evidence generation? Are you passionate about evidence and RWE as means to optimize Market Access for an innovative pipeline? 

If yes, then Novo Nordisk might be the right place for you since we are now looking for a new Global Project Director in Portfolio Strategy, Access & Pricing (PSAP). Join us for a life-changing career! 
  
The position 
As a member of the Global Payer Evidence team, you will have the opportunity to work with some of the most innovative pipeline assets in Novo Nordisk’s history. The team is in charge of Payer Evidence strategy and long-term evidence planning across the portfolio. 

In your role as the Global Project Director, you will be accountable for the evidence strategy for a given therapy area as well as the execution and communication of evidence, thereby shaping the strategic direction for new assets and build-up of new treatment paradigms. This also includes close cross-functional collaborations to align on evidence gaps and activities. 

Importantly, the role also involves promoting the understanding, application and scaling of (gen)AI in evidence generation as well as driving (gen)AI into relevant methods and processes in Market Access and PSAP.  

Key responsibilities: 

• Set direction for (Gen)AI in RWE for payer and Market Access purposes and implement this into our existing way of working with evidence and deliverables. Build the data architecture/framework to support the implementation of (Gen)AI into different deliverables, methods, processes, and ways of working within PSAP/GPE, working closely with key stakeholders
• Drive payer evidence strategy and tactics, and spearhead market access preparation for products in development and launch 
• Lead payer-relevant real-world evidence studies (incl. costed patient pathways, treat-ment patterns, patient preferences, and burden of illness, and set evidence direction for Global Market Access and operations 
• Own descriptive and statistical analyses from secondary RWD sources and manage ad-hoc evidence requests from affiliates to drive payer dialogues and HTA submissions, and anticipate and shape payer/HTA evidence requirements via publications and external engagement 
• Represent the payer view and PSAP/GPE in cross-functional evidence and (gen)AI forum and processes 

For these purposes, you will need to build and maintain a comprehensive network of stakeholders with expertise in Payer Evidence as well as AI in evidence generation both internally and externally. 

Qualifications 
We are seeking a candidate with expertise in data science, evidence generation, RWE and (gen)AI, who can bring innovation and breakthrough thinking to our team. Your work will contribute to development of winning evidence strategies and important transformation of how we work in evidence generation for our portfolio of innovation. 

To be successful in this role, you should have: 

• M.Sc./Ph.D. degree in a relevant scientific field, e.g. data science, epidemiology, AI, HEOR, economics, and at least 7 years of experience in evidence generation, data science and RWE, ideally within the pharmaceutical industry or consultancy 
• Strong technical/programming background and interest, including programming/coding and prompt engineering skills
• Strong grasp of RWE for payer and access purposes, incl. HTA  
• Insight of (gen)AI in relevant methodologies, statistics and work process optimization  
• Fluency in written and spoken English 

 On a personal level, you possess strong project and stakeholder management skills, as well as effective communication skills. Additionally, you have a strategic and growth mindset, with a problem-solving approach enabling you to identify solutions and influence decisions. Finally, your ability to build productive relationships with internal and external stakeholders across key markets and functions are highly desirable. 
  
About the department 
This is your opportunity to join an international and diverse, high-performing team in Copenhagen, Denmark, working with bright people on some of the most innovative products in Novo Nordisk. PSAP is an area dedicated to transforming data analytics, (gen)AI and evidence gen-eration in Market Access as well as driving commercial portfolio strategies. The area is crucial to the future commercial success of Novo Nordisk products. 
  
Working at Novo Nordisk 
We are a proud life-science company, and life is our reason to exist. We’re inspired by life in all its forms and shapes, ups and downs, opportunities and challenges. For employees at Novo Nordisk, life means many things – from the building blocks of life that form the basis of ground-breaking scientific research, to our rich personal lives that motivate and energise us to perform our best at work. Ultimately, life is why we’re all here - to ensure that people can lead a life independent of chronic disease.

Contact 
For further information please contact Mette Schrøder Hemels, VP of Global Payer Evidence at [email protected].
  
Deadline 
02 February 2025.  

You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. 

To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. 

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. 

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.